Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce ...

A RECENT investigation carried out in this laboratory revealed that rats treated with glucagon gained less weight and contained much less fat, protein and water than pair-fed controls. Since the ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce ...

IULILIA BURMISTROVA -- GETTY IMAGES Dec 9, 2024 56 mins ago ...

Study: Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review. Image Credit: Kmpzzz/Shutterstock.com In a recent study published ...

Nesfatin-1 infusion in the small intestine of NUCB2-knockout rats reduced hepatic glucose production via a gut – brain – liver circuit. Mechanistically, NUCB2/nesfatin-1 interacted directly with ...

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

Unger, R. H., and Eisentraut, A. M., Hormones in Blood, 1 (edit. by Gray, C. H., and Bacharach, A. L.), 113 (Academic Press, London, 1967).

The FDA put both peptides on its shortage list in 2022. Semaglutide is still on that list, while the FDA lifted its shortage ...

The published evidence identified also showed that insulin administration via NovoPen ® devices was for most patients easier, more convenient and quicker than with conventional syringes and that ...